Antiphospholipid Antibody Role in Acute Ischemic Stroke Patients with COVID-19: A Narrative Review
Acta Medica Philippina
; 56(13):5-11, 2022.
Article
in English
| Scopus | ID: covidwho-2146735
ABSTRACT
Antiphospholipid antibodies (aPL) are commonly found in humans after an infection. Its action can promote thrombosis via the activation of endothelial cells, platelets, and neutrophils. This autoantibody is the leading cause of antiphospholipid antibody syndrome (APS), characterized by widespread thrombosis in various vascular beds. COVID-19 also causes acute ischemic stroke (AIS) in the younger demographic, who previously was not considered a population at risk for AIS, which may be related to APS. This narrative review will discuss the role of aPL in COVID-19 patients who experienced AIS during infection. © 2022 University of the Philippines Manila. All rights reserved.
Full text:
Available
Collection:
Databases of international organizations
Database:
Scopus
Type of study:
Reviews
Language:
English
Journal:
Acta Medica Philippina
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS